Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
54.8 SEK | 0.00% | +3.40% | +20.04% |
May. 15 | Integrum Announces It Has Been Granted A Registered Trademark for OPRA® Implant System in the Eu | CI |
May. 02 | Integrum Expands Its Product Offering to the United Kingdom Market | CI |
Sales 2024 * | 107M 10.12M | Sales 2025 * | 151M 14.28M | Capitalization | 1.01B 95.5M |
---|---|---|---|---|---|
Net income 2024 * | 4M 378K | Net income 2025 * | 15M 1.42M | EV / Sales 2024 * | 9.23 x |
Net cash position 2024 * | 22.76M 2.15M | Net cash position 2025 * | 19.81M 1.87M | EV / Sales 2025 * | 6.56 x |
P/E ratio 2024 * |
747
x | P/E ratio 2025 * |
72.7
x | Employees | 34 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 48.7% |
1 week | +3.40% | ||
Current month | -4.20% | ||
1 month | -1.44% | ||
3 months | +27.44% | ||
6 months | +40.33% | ||
Current year | +20.04% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 64 | 97-12-31 | |
Jörgen Svanström
DFI | Director of Finance/CFO | - | 23-05-01 |
Mats Dotevall
COO | Chief Operating Officer | 62 | 23-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 18-12-31 | |
Bengt Sjöholm
CHM | Chairman | 71 | 18-12-31 |
Founder | 64 | 97-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 54.8 | 0.00% | 37,158 |
24-05-27 | 54.8 | +2.62% | 24,756 |
24-05-24 | 53.4 | -0.37% | 26,198 |
24-05-23 | 53.6 | +0.37% | 37,003 |
24-05-22 | 53.4 | +0.75% | 12,598 |
Delayed Quote Nasdaq Stockholm, May 28, 2024 at 11:12 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.04% | 95.21M | |
+5.07% | 19B | |
+5.86% | 14.17B | |
+10.34% | 10.61B | |
-17.69% | 2.08B | |
+3.10% | 1.74B | |
+15.03% | 1.43B | |
+10.00% | 594M | |
0.00% | 428M | |
+76.68% | 216M |
- Stock Market
- Equities
- INTEG B Stock